Loading clinical trials...
Loading clinical trials...
A Phase I Clinical Study to Evaluate the Tolerance and Safety of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesion(s) (CIN 2 and 3)
Conditions
Interventions
Cidofovir gel
Locations
1
Belgium
Erasme Hospital
Brussels, Belgium
Start Date
May 1, 2010
Primary Completion Date
September 1, 2010
Last Updated
October 21, 2010
NCT07011836
NCT05406856
NCT03617133
NCT00579163
NCT04579380
NCT07240753
Lead Sponsor
Mithra Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions